Remove Clinic Remove Diabetes Remove Hypertension Remove Individual
article thumbnail

SGLT-2 inhibitor, cardiovascular risk and outcome in patients with comorbidity of hypertension and diabetes [Cardiovascular disease]

Annals of Family Medicine

Context Two thirds of diabetes patients complicated with hypertension, and comorbidity increase 4-fold risk of atherosclerotic cardiovascular disease (ASCVD). Setting or Dataset Five electronic systems of community clinic. Population Studied individuals with comorbidity of hypertension and type 2 diabetes.

article thumbnail

Development of a Multidisciplinary Clinic for the Treatment of Obesity in a Canadian University Family Medicine Group (U-FMG) [Obesity, exercise and nutrition]

Annals of Family Medicine

of Canadians were at greater risk of chronic diseases due to their BMI, including type 2 diabetes, atherosclerosis, and hypertension. Population Studied Patients with obesity enrolled in the Méta-Santé clinic. Follow-up frequency, ranging from weekly to monthly for up to 12 months, is tailored to individual needs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Prevention of Dementia: Kristine Yaffe

GeriPal

There I was, extremely overly trained with brain stuff, and I wanted to learn how to do clinical research. I just thought there was so much we could learn and offer from every sense, from the clinical point of view, from the family point of view, from prevention, from treatment, epidemiology, et cetera. One might argue they still are.

article thumbnail

Multifactorial Drivers of Cognitive Decline in Diabetes

Physician's Weekly

prevalence of MCI in individuals with T2DM. Significant associations were observed with age (OR = 1.06, P = 0.01), female sex (OR = 1.23, P = 0.05), and diabetes duration (OR = 1.07, P = 0.03). 2025.1617248/full The post Multifactorial Drivers of Cognitive Decline in Diabetes first appeared on Physician's Weekly.

article thumbnail

How to manage GLP-1s in the hospital

Today's Hospitalist

THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. They presented a rapid clinical update Webinar in May 2025 hosted by the Society of Hospital Medicine.

article thumbnail

Q&A: Encouraging Cardiovascular Risk Screening in Psoriasis & Psoriatic Arthritis

Physician's Weekly

On top of that, many of these patients with psoriatic disease also have a higher prevalence of traditional risk factors such as hypertension , diabetes , dyslipidemia , obesity, smoking, etc. Providers need to understand their patients’ individualized needs. Merola, MD, MMSc, and vice president, Jose U. Intake is very important.

article thumbnail

Higher Dietary Inflammatory Index Tied to Elevated CHD Risk

Physician's Weekly

had hypertension, and 12.1% had diabetes. Findings revealed stronger associations in adults less than 75 years ( P <0.001), ( P =0.028), individuals with low total cholesterol ( P =0.004), and those with low Framingham risk scores ( P =0.005). The cohort’s mean age was 49.8±18.1 years; 47.4 % were male, 45.6%